COMMUNIQUÉS West-GlobeNewswire

-
INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update
01/08/2024 -
Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update
01/08/2024 -
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
01/08/2024 -
LeMaitre Q2 2024 Financial Results
01/08/2024 -
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
01/08/2024 -
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update
01/08/2024 -
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
01/08/2024 -
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
01/08/2024 -
Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results
01/08/2024 -
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
01/08/2024 -
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/08/2024 -
Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
01/08/2024 -
T2 Biosystems to Attend Upcoming Investor Conferences
01/08/2024 -
Merit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings
01/08/2024 -
Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio Scientific
01/08/2024 -
Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update
01/08/2024 -
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
01/08/2024 -
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
01/08/2024 -
Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results
01/08/2024
Pages